58 related articles for article (PubMed ID: 15634888)
1. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.
Crowe SR; Miller SC; Shenyo RM; Woodland DL
J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888
[TBL] [Abstract][Full Text] [Related]
2. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.
Belz GT; Xie W; Altman JD; Doherty PC
J Virol; 2000 Apr; 74(8):3486-93. PubMed ID: 10729122
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.
Berkhoff EG; Boon AC; Nieuwkoop NJ; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
J Virol; 2004 May; 78(10):5216-22. PubMed ID: 15113903
[TBL] [Abstract][Full Text] [Related]
4. Measuring the diaspora for virus-specific CD8+ T cells.
Marshall DR; Turner SJ; Belz GT; Wingo S; Andreansky S; Sangster MY; Riberdy JM; Liu T; Tan M; Doherty PC
Proc Natl Acad Sci U S A; 2001 May; 98(11):6313-8. PubMed ID: 11344265
[TBL] [Abstract][Full Text] [Related]
5. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
Price GE; Ou R; Jiang H; Huang L; Moskophidis D
J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
[TBL] [Abstract][Full Text] [Related]
6. Transience of MHC Class I-restricted antigen presentation after influenza A virus infection.
Mintern JD; Bedoui S; Davey GM; Moffat JM; Doherty PC; Turner SJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6724-9. PubMed ID: 19346476
[TBL] [Abstract][Full Text] [Related]
7. Division of labor between subsets of lymph node dendritic cells determines the specificity of the CD8⁺ T-cell recall response to influenza infection.
Suárez-Ramírez JE; Wu T; Lee YT; Aguila CC; Bouchard KR; Cauley LS
Eur J Immunol; 2011 Sep; 41(9):2632-41. PubMed ID: 21660939
[TBL] [Abstract][Full Text] [Related]
8. Vaccine efficacy and T helper cell differentiation change with aging.
Lefebvre JS; Lorenzo EC; Masters AR; Hopkins JW; Eaton SM; Smiley ST; Haynes L
Oncotarget; 2016 Jun; 7(23):33581-94. PubMed ID: 27177221
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Epitope-Polymer Vaccine Lodges Resident Memory T Cells Protecting Against Influenza Virus.
Liu Z; Kabir MT; Chen S; Zhang H; Wakim LM; Rehm BHA
Adv Healthc Mater; 2024 Jun; 13(15):e2304188. PubMed ID: 38411375
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccines: influenza virus challenge of a Th2/Tc2 immune response results in a Th2/Tc1 response in the lung.
Oran AE; Robinson HL
J Virol; 2004 Apr; 78(8):4376-80. PubMed ID: 15047852
[TBL] [Abstract][Full Text] [Related]
11. Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response.
Blevins LK; Wren JT; Holbrook BC; Hayward SL; Swords WE; Parks GD; Alexander-Miller MA
J Immunol; 2014 Nov; 193(10):5076-87. PubMed ID: 25311807
[TBL] [Abstract][Full Text] [Related]
12. Preemptive priming readily overcomes structure-based mechanisms of virus escape.
Valkenburg SA; Gras S; Guillonneau C; Hatton LA; Bird NA; Twist KA; Halim H; Jackson DC; Purcell AW; Turner SJ; Doherty PC; Rossjohn J; Kedzierska K
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5570-5. PubMed ID: 23493558
[TBL] [Abstract][Full Text] [Related]
13. Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response.
Hogan MJ; Maheshwari N; Begg BE; Nicastri A; Hedgepeth EJ; Muramatsu H; Pardi N; Miller MA; Reilly SP; Brossay L; Lynch KW; Ternette N; Eisenlohr LC
Nat Immunol; 2023 Nov; 24(11):1933-1946. PubMed ID: 37828378
[TBL] [Abstract][Full Text] [Related]
14. Diverse Epitope Specificity, Immunodominance Hierarchy, and Functional Avidity of Effector CD4 T Cells Established During Priming Is Maintained in Lung After Influenza A Virus Infection.
Richards KA; DiPiazza AT; Rattan A; Knowlden ZAG; Yang H; Sant AJ
Front Immunol; 2018; 9():655. PubMed ID: 29681900
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice.
Cummins NW; Weaver EA; May SM; Croatt AJ; Foreman O; Kennedy RB; Poland GA; Barry MA; Nath KA; Badley AD
FASEB J; 2012 Jul; 26(7):2911-8. PubMed ID: 22490782
[TBL] [Abstract][Full Text] [Related]
16. Sequential Early-Life Infections Alter Peripheral Blood Transcriptomics in Aging Female Mice but Not the Response to De Novo Infection with Influenza Virus or M. tuberculosis.
Lanzer KG; Cookenham T; Lehrmann E; Zhang Y; Duso D; Xie Q; Reiley WW; Becker KG; Blackman MA
Immunohorizons; 2023 Aug; 7(8):562-576. PubMed ID: 37555847
[TBL] [Abstract][Full Text] [Related]
17. Structural determinants of T-cell receptor bias in immunity.
Turner SJ; Doherty PC; McCluskey J; Rossjohn J
Nat Rev Immunol; 2006 Dec; 6(12):883-94. PubMed ID: 17110956
[TBL] [Abstract][Full Text] [Related]
18. Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.
Carascal MB; Pavon RDN; Rivera WL
Front Immunol; 2022; 13():878943. PubMed ID: 35663997
[TBL] [Abstract][Full Text] [Related]
19. A Novel H-2
Uddbäck I; Kohlmeier JE; Thomsen AR; Christensen JP
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337006
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
